ProShare Advisors’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $567K | Sell |
15,741
-3,807
| -19% | -$137K | ﹤0.01% | 1056 |
|
|
2025
Q1 | $609K | Sell |
19,548
-1,495
| -7% | -$46.5K | ﹤0.01% | 993 |
|
|
2024
Q4 | $537K | Sell |
21,043
-5,438
| -21% | -$139K | ﹤0.01% | 1232 |
|
|
2024
Q3 | $749K | Sell |
26,481
-1,366
| -5% | -$38.6K | ﹤0.01% | 909 |
|
|
2024
Q2 | $734K | Sell |
27,847
-3,458
| -11% | -$91.2K | ﹤0.01% | 817 |
|
|
2024
Q1 | $951K | Buy |
31,305
+2,764
| +10% | +$83.9K | ﹤0.01% | 801 |
|
|
2023
Q4 | $802K | Sell |
28,541
-807
| -3% | -$22.7K | ﹤0.01% | 818 |
|
|
2023
Q3 | $797K | Buy |
29,348
+348
| +1% | +$9.45K | ﹤0.01% | 767 |
|
|
2023
Q2 | $891K | Sell |
29,000
-1,724
| -6% | -$53K | ﹤0.01% | 754 |
|
|
2023
Q1 | $1.11M | Sell |
30,724
-11,377
| -27% | -$410K | ﹤0.01% | 711 |
|
|
2022
Q4 | $1.66M | Sell |
42,101
-501
| -1% | -$19.8K | 0.01% | 650 |
|
|
2022
Q3 | $1.71M | Buy |
42,602
+2,778
| +7% | +$112K | 0.01% | 643 |
|
|
2022
Q2 | $1.67M | Sell |
39,824
-13,142
| -25% | -$552K | 0.01% | 671 |
|
|
2022
Q1 | $2.06M | Sell |
52,966
-16,469
| -24% | -$641K | ﹤0.01% | 712 |
|
|
2021
Q4 | $2.77M | Sell |
69,435
-30,176
| -30% | -$1.2M | 0.01% | 696 |
|
|
2021
Q3 | $3.6M | Buy |
99,611
+25,899
| +35% | +$936K | 0.01% | 580 |
|
|
2021
Q2 | $3.02M | Buy |
73,712
+18,398
| +33% | +$754K | 0.01% | 627 |
|
|
2021
Q1 | $2.41M | Sell |
55,314
-6,118
| -10% | -$267K | 0.01% | 642 |
|
|
2020
Q4 | $3.08M | Buy |
+61,432
| New | +$3.08M | 0.01% | 532 |
|